Atrophic Muscular Disorders clinical trials at UC Irvine

1 research study open to eligible people

Showing trials for

  • PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

    open to eligible people ages 18-60

    The primary purpose of the study is to evaluate the safety and tolerability of single intravenous (IV) doses of PGN-EDODM1 administered to participants with Myotonic Dystrophy Type 1 (DM1). The study consists of 2 periods: A Screening Period (up to 30 days) and a Treatment and Observation Period (16 weeks).

    Irvine 5359777, California 5332921 and other locations

Last updated: